Here, we identify both STMN2 and UNC13A cryptic exons in Alzheimer’s disease patients, that correlate with TDP-43 pathology burden, but not with amyloid-β or tau deposits. This evidence concerns the gene STMN2 and early-onset autosomal dominant Alzheimer disease.